Literature DB >> 9441676

Autonomous neural axis formation by ectopic expression of the protooncogene c-ski.

L S Amaravadi1, A W Neff, J P Sleeman, R C Smith.   

Abstract

The ski oncogene was originally isolated as an avian retroviral gene with the ability to induce quail embryonic cells to differentiate into muscle. Mice containing a chicken c-ski transgene exhibit postnatal hypertrophy of skeletal muscle. Xenopus ski (Xski) protein is maternal and present throughout early development. We show that overexpression of Xski RNA in Xenopus embryos results in the cell-autonomous induction of secondary neural axis formation. Injection of Xski RNA into prospective endodermal cells resulted in the formation of an ectopic neural tube-like structure and cells derived from the injected blastomeres populated the spinal cord. Injected Xski RNA was able to induce neural-specific gene expression directly in ectodermal explants in the absence of the expression of mesodermal markers. The widespread distribution of ski protein in the early gastrula embryo including the dorsal animal region supports a role for ski in neural axis formation in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9441676     DOI: 10.1006/dbio.1997.8780

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  9 in total

1.  Ski represses bone morphogenic protein signaling in Xenopus and mammalian cells.

Authors:  W Wang; F V Mariani; R M Harland; K Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  The SMAD-binding domain of SKI: a hotspot for de novo mutations causing Shprintzen-Goldberg syndrome.

Authors:  Dorien Schepers; Alexander J Doyle; Gretchen Oswald; Elizabeth Sparks; Loretha Myers; Patrick J Willems; Sahar Mansour; Michael A Simpson; Helena Frysira; Anneke Maat-Kievit; Rick Van Minkelen; Jeanette M Hoogeboom; Geert R Mortier; Hannah Titheradge; Louise Brueton; Lois Starr; Zornitza Stark; Charlotte Ockeloen; Charles Marques Lourenco; Ed Blair; Emma Hobson; Jane Hurst; Isabelle Maystadt; Anne Destrée; Katta M Girisha; Michelle Miller; Harry C Dietz; Bart Loeys; Lut Van Laer
Journal:  Eur J Hum Genet       Date:  2014-04-16       Impact factor: 4.246

3.  Transformation of hematopoietic cells by the Ski oncoprotein involves repression of retinoic acid receptor signaling.

Authors:  R Dahl; M Kieslinger; H Beug; M J Hayman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

4.  The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling.

Authors:  K Luo; S L Stroschein; W Wang; D Chen; E Martens; S Zhou; Q Zhou
Journal:  Genes Dev       Date:  1999-09-01       Impact factor: 11.361

5.  Regulation of early xenopus embryogenesis by Smad ubiquitination regulatory factor 2.

Authors:  Shaonli Das; Chenbei Chang
Journal:  Dev Dyn       Date:  2012-06-15       Impact factor: 3.780

Review 6.  Ski and SnoN, potent negative regulators of TGF-beta signaling.

Authors:  Julien Deheuninck; Kunxin Luo
Journal:  Cell Res       Date:  2009-01       Impact factor: 25.617

7.  Interaction with Smad4 is indispensable for suppression of BMP signaling by c-Ski.

Authors:  Masafumi Takeda; Masafumi Mizuide; Masako Oka; Tetsuro Watabe; Hirofumi Inoue; Hiroyuki Suzuki; Toshiro Fujita; Takeshi Imamura; Kohei Miyazono; Keiji Miyazawa
Journal:  Mol Biol Cell       Date:  2003-12-29       Impact factor: 4.138

8.  Epigenetic profiling of ADHD symptoms trajectories: a prospective, methylome-wide study.

Authors:  E Walton; J-B Pingault; C A M Cecil; T R Gaunt; C L Relton; J Mill; E D Barker
Journal:  Mol Psychiatry       Date:  2016-05-24       Impact factor: 15.992

9.  Transcriptional cofactors Ski and SnoN are major regulators of the TGF-β/Smad signaling pathway in health and disease.

Authors:  Angeles C Tecalco-Cruz; Diana G Ríos-López; Genaro Vázquez-Victorio; Reyna E Rosales-Alvarez; Marina Macías-Silva
Journal:  Signal Transduct Target Ther       Date:  2018-06-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.